Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Psychosurgery01:30

Psychosurgery

1.3K
Psychosurgery, the surgical alteration or permanent removal of brain tissue to alleviate severe psychological conditions, stands as one of the most radical and controversial treatments in the history of mental health care. Its development and application have evolved significantly, marked by dramatic shifts in scientific understanding and ethical perspectives.
Historical Development of Psychosurgery
In the 1930s, Portuguese neurologist Antonio Egas Moniz introduced a surgical procedure designed...
1.3K
Psychosis: Goals of Pharmacotherapy01:26

Psychosis: Goals of Pharmacotherapy

434
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
434
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

5.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.8K
Drug Therapy01:28

Drug Therapy

226
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
226
Human Genetics01:28

Human Genetics

1.4K
Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
1.4K
Treatment Strategies for Psychological Disorders01:24

Treatment Strategies for Psychological Disorders

559
Treatment approaches for psychological disorders fall into three main categories: psychological, biological, and sociocultural. Each approach targets different aspects of mental health, requiring varying levels of education and training.
Psychological therapies focus on modifying emotions, thoughts, and behaviors through talking, interpreting, listening, rewarding, challenging, and modeling. Clinical psychologists, counselors, and social workers commonly practice psychotherapy. Clinical...
559

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Monocyte abundance and glycolytic reprogramming associate with motivational impairment in depression.

Brain, behavior, and immunity·2026
Same author

Predicting Post-Radiotherapy Epigenetic Age Acceleration From Pre-Treatment Data Using a Machine Learning Framework in Head and Neck Cancer Patients.

Cancer medicine·2026
Same author

Depressive symptoms and perceived stress in patients with head and neck cancer undergoing intensity-modulated radiation therapy: A longitudinal study.

European journal of oncology nursing : the official journal of European Oncology Nursing Society·2026
Same author

Chronic pain in a modern virally suppressed HIV cohort is associated with disability and poorer mental health.

Scientific reports·2026
Same author

Inhibition of Cxcr4 chemokine receptor signaling improves habituation learning in a zebrafish model of neurofibromatosis.

Disease models & mechanisms·2026
Same author

Synaptic effects of interleukin-6 on human iPSC-derived dopaminergic neurons.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology·2026
Same journal

The Clinical Threshold for Treatment in Psychiatry.

JAMA psychiatry·2026
Same journal

Semaglutide in Schizophrenia-A Top Clinical Trial.

JAMA psychiatry·2026
Same journal

Adolescent Peers' Diagnoses and Genetic Predispositions and Subsequent Risk of Mental Disorders.

JAMA psychiatry·2026
Same journal

Use and Misuse of GLP-1 Receptor Agonists Among People With Eating Disorders.

JAMA psychiatry·2026
Same journal

Connectivity- vs Scalp-Based Targeting of Accelerated Transcranial Magnetic Stimulation for Depression: A Randomized Clinical Trial.

JAMA psychiatry·2026
Same journal

Neurometabolites and Antipsychotic Response in Psychosis: A Mega-Analysis.

JAMA psychiatry·2026
See all related articles

Related Experiment Video

Updated: Jan 7, 2026

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
10:28

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Published on: July 24, 2019

15.9K

Implementing Precision Medicine in Psychiatry.

Federico Cevoli1, Husseini K Manji2,3,4, Andrew H Miller5

  • 1Fondation FondaMental, Créteil, France.

JAMA Psychiatry
|December 10, 2025
PubMed
Summary
This summary is machine-generated.

Drug discovery for neuropsychiatric disorders needs a paradigm shift. Precision psychiatry, driven by biomarker discovery and reformed clinical trials, offers a path to more effective treatments for mental health conditions.

More Related Videos

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
07:31

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack

Published on: May 15, 2020

7.5K
Author Spotlight: Integrating Computational and Experimental Approaches in Precision Oncology
07:03

Author Spotlight: Integrating Computational and Experimental Approaches in Precision Oncology

Published on: December 1, 2023

1.4K

Related Experiment Videos

Last Updated: Jan 7, 2026

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
10:28

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Published on: July 24, 2019

15.9K
Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
07:31

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack

Published on: May 15, 2020

7.5K
Author Spotlight: Integrating Computational and Experimental Approaches in Precision Oncology
07:03

Author Spotlight: Integrating Computational and Experimental Approaches in Precision Oncology

Published on: December 1, 2023

1.4K

Area of Science:

  • Neuroscience and Psychiatry
  • Translational Medicine

Background:

  • Neuropsychiatric disorders represent a significant global health burden.
  • Limited progress in developing mechanism-based treatments for psychiatric disorders over the past 50 years.
  • Existing drug discovery pipelines have yielded few validated treatments.

Purpose of the Study:

  • To identify reasons for slow progress in mental disorder drug discovery.
  • To propose a paradigm shift towards precision psychiatry.
  • To outline recommendations for advancing psychiatric drug development.

Main Methods:

  • Review of current challenges in psychiatric drug discovery.
  • Analysis of reasons for limited success in developing mechanism-based treatments.
  • Discussion of potential solutions including biomarker discovery and clinical trial reform.

Main Results:

  • Identified key barriers hindering effective drug discovery for mental disorders.
  • Recommended a transition to precision psychiatry, leveraging biomarkers for targeted treatments.
  • Advocated for reformed clinical trial methodologies, including biomarker-informed adaptive designs.

Conclusions:

  • Precision psychiatry offers a promising framework for developing novel treatments for neuropsychiatric disorders.
  • Biomarker discovery and innovative clinical trial designs are crucial for accelerating progress.
  • Increased investment and cross-sector collaboration are essential to realize the potential of precision psychiatry.